Skip to main content
Livermore
Livermore
ZHEN

Tango Therapeutics, Inc.

TNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001819133

In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.

Holders of 5% or more of TNGX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tango Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of TNGX
HolderLatest formStakeChangeFirst filedLatest filingFiling
BCTG Holdings, LLC13D/A10.00%10.7M shares–Jan 2, 20251 filingJan 2, 2025SEC
Farallon Partners L L C13G/A9.99%13.5M shares–Feb 6, 20261 filingFeb 6, 2026SEC
RTW Investments, LP13G9.30%13.3M sharesNewMay 15, 20261 filingMay 15, 2026SEC
Adage Capital Management, L.P.13G/A8.98%12.8M shares+1.10 ppfrom 7.88%Aug 12, 20254 filingsMay 13, 2026SEC
TCG Crossover GP II, LLC13G/A8.10%11.6M shares−1.89 ppfrom 9.99%Nov 14, 20253 filingsMay 15, 2026SEC
Farallon Capital Partners, L.P.13G/A7.80%11.3M shares−1.90 ppfrom 9.70%Jun 13, 20254 filingsMay 11, 2026SEC
FMR LLC13G6.90%9.91M shares+6.90 ppfrom 0.00%Dec 6, 20242 filingsMay 6, 2026SEC
BlackRock, Inc.13G6.30%8.48M shares+1.30 ppfrom 5.00%Jul 17, 20252 filingsJan 21, 2026SEC
Woodline Partners LP13G/A5.60%8.00M shares−1.90 ppfrom 7.50%Aug 14, 20253 filingsMay 15, 2026SEC
Nextech Crossover I GP S.a r.l.13G/A5.10%7.27M shares–May 15, 20261 filingMay 15, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

32 Schedule 13D and 13G filings on Tango Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on TNGX
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 15, 20264:24 PM ETTCG Crossover GP II, LLCand 2 others13G/A8.10%11.6M shares−1.89 ppfrom 9.99%Mar 31, 2026SEC
May 15, 20264:23 PM ETNextech Crossover I GP S.a r.l.and 4 others13G/A5.10%7.27M shares–Mar 31, 2026SEC
May 15, 20269:16 AM ETWoodline Partners LP13G/A5.60%8.00M shares−1.90 ppfrom 7.50%Mar 31, 2026SEC
May 15, 20268:34 AM ETRTW Investments, LPand 1 other13G9.30%13.3M sharesNewMar 31, 2026SEC
May 13, 20269:18 AM ETAdage Capital Management, L.P.and 2 others13G/A8.98%12.8M shares+1.10 ppfrom 7.88%Mar 31, 2026SEC
May 11, 20268:49 AM ETFarallon Capital Partners, L.P.and 27 others13G/A7.80%11.3M shares−1.90 ppfrom 9.70%Mar 31, 2026SEC
May 6, 202611:40 AM ETFMR LLCand 1 other13G6.90%9.91M shares+6.90 ppfrom 0.00%Mar 31, 2026SEC
May 4, 20262:39 PM ETInvus Global Management, LLCand 7 others13G/A4.00%5.66M shares−2.10 ppfrom 6.10%Below 5%Mar 31, 2026SEC
Mar 27, 20261:31 PM ETVanguard Group Inc13G/A0.00%0 shares−5.01 ppfrom 5.01%Below 5%Mar 13, 2026SEC
Feb 17, 20266:29 PM ETEcoR1 Capital, LLCand 2 others13G/A0.00%0 shares−9.90 ppfrom 9.90%Below 5%Dec 31, 2025SEC
Feb 17, 20264:22 PM ETTCG Crossover GP II, LLCand 2 others13G/A9.99%13.5M shares+3.69 ppfrom 6.30%Dec 31, 2025SEC
Feb 17, 20263:22 PM ETWoodline Partners LP13G/A7.50%10.1M shares+1.90 ppfrom 5.60%Dec 31, 2025SEC
Feb 13, 202611:47 AM ETInvus Global Management, LLCand 7 others13G/A6.10%8.17M shares+0.80 ppfrom 5.30%Dec 31, 2025SEC
Feb 12, 20269:11 AM ETAdage Capital Management, L.P.and 2 others13G7.88%10.6M shares+5.62 ppfrom 2.26%Dec 31, 2025SEC
Feb 10, 20264:15 PM ETThird Rock Ventures IV, L.P.and 2 others13D/A4.74%6.37M shares−1.11 ppfrom 5.85%Below 5%Feb 6, 2026SEC
Feb 6, 20264:11 PM ETFarallon Partners L L Cand 30 others13G/A9.99%13.5M shares–Dec 31, 2025SEC
Jan 30, 20262:44 PM ETVanguard Group Inc13G5.01%6.75M sharesNewDec 31, 2025SEC
Jan 21, 202612:30 PM ETBlackRock, Inc.13G6.30%8.48M shares+1.30 ppfrom 5.00%Dec 31, 2025SEC
Nov 21, 20254:15 PM ETThird Rock Ventures IV, L.P.and 2 others13D/A5.85%7.87M shares−1.12 ppfrom 6.97%Nov 19, 2025SEC
Nov 14, 20254:23 PM ETTCG Crossover GP II, LLCand 2 others13G/A6.30%8.54M shares–Sep 30, 2025SEC
Nov 14, 20254:15 PM ETThird Rock Ventures IV, L.P.and 2 others13D/A6.97%9.37M shares–Nov 12, 2025SEC
Nov 13, 20259:00 AM ETAdage Capital Management, L.P.and 2 others13G/A2.26%2.51M shares−3.19 ppfrom 5.45%Below 5%Sep 30, 2025SEC
Nov 12, 202512:17 PM ETFarallon Capital Partners, L.P.and 27 others13G/A9.70%10.8M shares+1.30 ppfrom 8.40%Sep 30, 2025SEC
Sep 22, 20255:22 PM ETInvus Global Management, LLCand 7 others13G5.30%5.88M sharesNewSep 19, 2025SEC
Aug 14, 202511:56 AM ETWoodline Partners LP13G5.60%6.03M sharesNewJun 30, 2025SEC
Aug 13, 20255:00 PM ETFarallon Capital Partners, L.P.and 27 others13G/A8.40%9.16M shares+1.80 ppfrom 6.60%Jun 30, 2025SEC
Aug 12, 20259:06 AM ETAdage Capital Management, L.P.and 2 others13G5.45%5.91M sharesNewJun 30, 2025SEC
Jul 17, 20258:12 PM ETBlackRock, Inc.13G5.00%5.46M sharesNewJun 30, 2025SEC
Jun 13, 20255:25 PM ETFarallon Capital Partners, L.P.and 27 others13G6.60%7.18M sharesNewJun 6, 2025SEC
Feb 14, 202512:33 PM ETEcoR1 Capital, LLCand 2 others13G/A9.90%10.6M shares–Dec 31, 2024SEC
Jan 2, 20257:07 AM ETBCTG Holdings, LLCand 3 others13D/A10.00%10.7M shares–Dec 30, 2024SEC
Dec 6, 202411:14 AM ETFMR LLCand 1 other13G/A0.00%13.4K shares–Below 5%Nov 29, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Tango Therapeutics, Inc. shares.

No Form 144 notices for Tango Therapeutics, Inc. are on file.